| 0.0404 Data as of May 21 |  -0.0016 / -3.81%Today’s Change | 0.00 Today|||52-Week Range 0.20 | -69.39% Year-to-Date |
| Previous close | 0.04 |
| Today’s open | 0.04 |
| Day’s range | -- - -- |
| Volume | 1,653,961 |
| Average volume (3 months) | 3,755,619 |
| Market cap | -- |
| Dividend yield | -- |
| Earnings growth (last year) | -19,900.00% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | 31.81 |
| Price/Book | -- |
| No competitors data available. |
| Next reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $223.6K |
| Annual profit (last year) | -$4.4M |
| Net profit margin | -1,985.84% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Gerald E. Commissiong |
Chief Financial Officer, Secretary & Treasurer Marc E. Faerber, CPA |
Corporate headquarters Sunnyvale, California |
.
